These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 1405259)

  • 1. [Phenotypic familial correlations of prostacyclin and thromboxane A2 levels in children and adolescents with or without hereditary predisposition to ischemic heart disease].
    Akimov EV
    Kardiologiia; 1992 May; 32(5):41-3. PubMed ID: 1405259
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prostacyclin and thromboxane A2 levels in children and adolescents with an inherited predisposition to coronary heart disease: a family study.
    Akimova EV
    Coron Artery Dis; 1994 Sep; 5(9):761-5. PubMed ID: 7858766
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Prostacyclin-thromboxane system in children and adolescents with a high risk of developing ischemic heart disease].
    Akimova EV
    Vopr Med Khim; 1992; 38(2):47-9. PubMed ID: 1413633
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Status of the prostacyclin-thromboxane A2 system in patients with ischemic heart disease during induced myocardial ischemia].
    Nikolaeva LF; Aleshin OI; Pavlov NA; Pomerantsev EV; Masenko VP
    Sov Med; 1988; (4):3-6. PubMed ID: 3043710
    [No Abstract]   [Full Text] [Related]  

  • 5. [Pharmacological correction of disorders of the prostacyclin- thromboxane balance in ischemic heart disease: problems and prospects].
    Markov KhM
    Kardiologiia; 1990 Apr; 30(4):111-8. PubMed ID: 2118578
    [No Abstract]   [Full Text] [Related]  

  • 6. Prostacyclin and thromboxane levels of children of parents suffering from early ischemic heart disease.
    Mihai K; Petó J; Kolthay E; Makáry A
    Acta Paediatr Hung; 1991; 31(1):113-8. PubMed ID: 1867870
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Kinetics of thromboxane A2 and prostacyclin during reperfusion after induced ischemia in canine hearts].
    Nomura F; Hirose H; Matsuda H; Nakano S; Shirakura R; Ohtani M; Kaneko M; Sasako Y; Kawashima Y; Kuzuya T
    Kyobu Geka; 1985 Jan; 38(1):46-9. PubMed ID: 3884863
    [No Abstract]   [Full Text] [Related]  

  • 8. [Thromboxane A2 and prostacyclin in patients with chronic glomerulonephritis and coronary heart disease in contrast media nephrotoxicity. Protective effects of calcium antagonists].
    Dzgoeva FU; Kutyrina IM
    Ter Arkh; 2000; 72(6):42-5. PubMed ID: 10900648
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Prostacyclin-thromboxane balance and risk factors of ischemic heart disease].
    Markov KhM
    Kardiologiia; 1989 Sep; 29(9):5-12. PubMed ID: 2512411
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The level of vasoactive prostanoids in patients with ischemic heart disease in the early period following aortocoronary bypass].
    Bakhoviddinova GSh
    Vrach Delo; 1991 Sep; (9):36-8. PubMed ID: 1759428
    [No Abstract]   [Full Text] [Related]  

  • 11. [Effect of myocardial ischemia on prostacyclin and thromboxane levels in arterial and coronary venous blood].
    Vakhliaev VD; Meshcheriakova SA; Bol'shakova TD; Bogatyrev IV; Makolkin VI
    Kardiologiia; 1988 Mar; 28(3):41-5. PubMed ID: 3288802
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prostaglandin E2, prostacyclin, and thromboxane changes during nonpulsatile cardiopulmonary bypass in humans.
    Faymonville ME; Deby-Dupont G; Larbuisson R; Deby C; Bodson L; Limet R; Lamy M
    J Thorac Cardiovasc Surg; 1986 Jun; 91(6):858-66. PubMed ID: 3520158
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The prostacyclin-thromboxane system and bronchial patency in patients with pulmonary tuberculosis].
    Petrenko VI
    Lik Sprava; 1996; (3-4):69-71. PubMed ID: 9035887
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The role of thromboxane A2 and prostacyclin in the pathogenesis of diabetes mellitus in children and adolescents].
    Vakhrusheva LL; Kniazev IuA; Martynova MI; Pirogova LB
    Pediatriia; 1991; (2):18-22. PubMed ID: 2057285
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Blood thromboxane A2 and prostaglandin I2 levels and platelet phospholipid fatty acid composition ratios in ischemic heart disease and cerebral infarction--with special reference to the effect of antiplatelet agents].
    Inoue T
    Nihon Ronen Igakkai Zasshi; 1983 Jul; 20(4):294-304. PubMed ID: 6363769
    [No Abstract]   [Full Text] [Related]  

  • 16. [Prostaglandins and ischemic cardiopathy].
    Strano A; Davì G
    Cardiologia; 1985 Apr; 30(4):261-4. PubMed ID: 3914359
    [No Abstract]   [Full Text] [Related]  

  • 17. [Drug modulation of thromboxane A2/prostacyclin balance and lipid peroxidation in patients with coronary artery disease].
    Zhao X; Zhang YH; Feng HF
    Zhonghua Nei Ke Za Zhi; 1990 Aug; 29(8):476-8, 510-1. PubMed ID: 2086017
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Changes in prostacyclin and thromboxane A2 in coronary circulation, and their relation to coronary hemodynamics during reperfusion after global ischemia in canine hearts].
    Nomura F
    Nihon Kyobu Geka Gakkai Zasshi; 1985 Nov; 33(11):2109-17. PubMed ID: 3912439
    [No Abstract]   [Full Text] [Related]  

  • 19. [The content of stable forms of prostacyclin I2 and thromboxane A2 in the blood plasma in diabetic angiopathies].
    Sergienko AA
    Probl Endokrinol (Mosk); 1991; 37(4):24-6. PubMed ID: 1788186
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Connection between plasma thromboxane and prostacyclin levels in the metabolic control of diabetic children].
    Orosz L; Udvardy M; Vincze P; Fehér A; Madácsy L
    Orv Hetil; 1989 Jan; 130(3):125-8. PubMed ID: 2643785
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.